Harry Welten
Board member and Chief Financial Officer
Business and Management
ProteoMedix
Switzerland
Biography
Harry Welten, MBA, serves as Board member and Chief Financial Officer of Kuros Biosiences. From June 2010 to January 2016 he served as Executive Vice President and Chief Financial Officer of Cytos. He has 20 years of international executive experience, more than eleven of which as a CFO in the biotech industry. Prior to joining Cytos, Mr. Welten was CFO at Nitec Pharma AG and Arpida AG, both in Switzerland. Prior to joining Arpida, he held various senior management positions at UBS group including Director at UBS Warburg in New York. He is a member of the Board of Directors of Anokion, BiognoSYS AG, Horizon Pharma AG and BioSupport AG, and a member of the foundation council of HBM Foundation.
Research Interest
Business Development
